Evidence map›Paper›PMID 38075871›Full record

ArticleFrontiers in microbiology2023

Genomic analyses of

Amy Pham, James G Volmer, Daniel C Chambers, Daniel J Smith, David W Reid, Lucy Burr, Timothy J Wells

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Microorganisms · 2025
    Review
  2. Article
  3. Article
  4. Cloaking antibodies are prevalent inFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Amy PhamFrazer Institute, The University of Queensland, Brisbane, QLD, Australia.
James G VolmerCentre for Microbiome Research, Queensland University of Technology, Brisbane, QLD, Australia.
Daniel C ChambersQueensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, QLD, Australia.
Daniel J SmithFaculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
David W ReidThe Adult Cystic Fibrosis Centre and Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia.
Lucy BurrDepartment of Respiratory Medicine, Mater Health, South Brisbane, QLD, Australia.
Timothy J WellsFrazer Institute, The University of Queensland, Brisbane, QLD, Australia.
The University of Queensland · AUMater Health Services · AUPrince Charles Hospital · AUQIMR Berghofer Medical Research Institute · AUQueensland University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The Methods: Here, we genomically characterise Results: We demonstrate that Discussion: Based on our phylogenetic and comparative genomic analyses, we suggest stratifying

Indexed as

Burkholderia anthinaBurkholderia cepacia complexcomparative genomicscystic fibrosissiderophore

Identifiers

PMID38075871
PMCPMC10702961
OpenAlexW4388940631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.